DxLab Inc. (DxLab) is a biotech startup, spun out of MIT and Harvard in September 2020, developing and commercializing a next-generation point-of-care (POC) diagnostic solution for rapid, on-site detection of dangerous pathogens. Combining proprietary platform technology with novel target detection and signal processing methods, we are advancing a pipeline of rapid POC tests.
Japanese multinational technology company in office equipment, optical systems for industrial use, and diagnostic imaging systems seeks startups for new innovative technologies, devices and systems.
Siam Cement Group (SCG) of Bangkok, Thailand is establishing a new business in home healthcare, and look for MIT-connected startups that wish to partner with them on new technologies or field prototypes in Southeast Asia. Including areas such as: telemonitoring devices; tele-medicine, medical devices, home diagnostics, rapid diagnoses, sterilization of surfaces and air, etc.
MIT Startup Exchange will select 4 startups to present and exhibit at the 2025 MIT Health & Science Forum on May 8.
Hyundai Mobis seeks startups for partnerships around healthcare technologies:
Bringing Rapid and Accurate Diagnostic Testing Where Needed Most
Bringing rapid and accurate diagnostic testing where needed most
Ho-Jun Suk; Co-Founder & CEO, DXLab